4//SEC Filing
Harrington-Smith Kristen 4
Accession 0001209191-22-010985
CIK 0001828522other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:26 PM ET
Size
5.6 KB
Accession
0001209191-22-010985
Insider Transaction Report
Form 4
Harrington-Smith Kristen
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15+40,000→ 40,000 totalExercise: $4.61Exp: 2032-02-14→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on February 15, 2022, subject to the Reporting Person's continued service with the Issuer through each vesting date.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001894310
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:26 PM ET
- Size
- 5.6 KB